| Literature DB >> 33986820 |
Jiaxing Feng1, Jing Wang2, Yuehui Zhang3, Yizhuo Zhang1, Liyan Jia3, Dongqi Zhang1, Jiao Zhang4, Yanhua Han3, Shoujuan Luo5.
Abstract
Female infertility is a state of fertility disorder caused by multiple reasons. The incidence of infertility for females has significantly increased due to various factors such as social pressure, late marriage, and late childbirth, and its harm includes heavy economic burden, psychological shadow, and even marriage failure. Conventional solutions, such as hormone therapy, in vitro fertilization (IVF), and embryo transfer, have the limitations of unsatisfied obstetric outcomes and serious adverse events. Currently, complementary and alternative medicine (CAM), as a new treatment for infertility, is gradually challenging the dominant position of traditional therapies in the treatment of infertility. CAM claims that it can adjust and harmonize the state of the female body from a holistic approach to achieve a better therapeutic effect and has been increasingly used by infertile women. Meanwhile, some controversial issues also appeared; that is, some randomized controlled trials (RCTs) confirmed that CAM had no obvious effect on infertility, and the mechanism of its effect could not reach a consensus. To clarify CAM effectiveness, safety, and mechanism, this paper systematically reviewed the literature about its treatment of female infertility collected from PubMed and CNKI databases and mainly introduced acupuncture, moxibustion, and oral Chinese herbal medicine. In addition, we also briefly summarized psychological intervention, biosimilar electrical stimulation, homeopathy, hyperbaric oxygen therapy, etc.Entities:
Year: 2021 PMID: 33986820 PMCID: PMC8093064 DOI: 10.1155/2021/6634309
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Summary of randomized studies of the effect of acupuncture on infertility outcomes.
| Study ID | Design | Sample size | Interventions | Outcomes | Limitation |
|---|---|---|---|---|---|
| 26 | RCT | 160 | Treatment arm: acupuncture intervention | Treatment arm: PR, 42.5% [34 of 80] | Not mentioned blindness |
|
| |||||
| 27 | Double-blind, RCT | 225 | Treatment arm: acupuncture intervention | Treatment arm: PR, 33.6%; OPR, 15.6% | Small sample size |
|
| |||||
| 28 | RCT | 60 | Treatment arm: acupuncture combined with TCM intervention | Treatment arm: PR, 26.7% [8 of 30] | Not mentioned blindness |
|
| |||||
| 31 | Double-blind, RCT | 1000 | Treatment arms: active acupuncture plus clomiphene group; active acupuncture plus placebo group | There were no significant differences in outcomes of LBR between treatment arms and control arms | |
|
| |||||
| 34 | RCT | 62 | Treatment arm: acupuncture intervention | There were no significant differences in outcomes of OPR between the two groups | Not mentioned blindness |
|
| |||||
| 47 | Single-blind, RCT | 60 | Treatment arm: auricular acupuncture intervention | Auricular acupuncture revealed a significant increase in ghrelin level and decrease in leptin level than sham auricular acupuncture | Single-blind trial |
Note: RCT: randomized clinical trial; PR: pregnancy rate; OPR: ongoing pregnancy rate; LBR: live birth rate. P< 0.05 versus treatment arm.
Summary of randomized studies of the effect of CHM on infertility outcomes.
| Study ID | Design | Sample size | Interventions | Outcomes | Composition | Limitation |
|---|---|---|---|---|---|---|
| 97 | RCT | 150 | Treatment arm: group B : CC + Zhushi Tiaojing Cuyun formula | Treatment arm: PR, group B: 52% [26 of 50] | Zhushi Tiaojing Cuyun formula: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 98 | RCT | 80 | Treatment arm: Bushen Peiyuan Yanggong decoction + estrogen + progesterone | Treatment arm: PR, 57.50% [23 of 40] | Bushen Peiyuan Yanggong decoction: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 100 | RCT | 120 | Treatment arm: Yuyin Ling + clomiphene | Treatment arm: PR, 46.7% [28 of 60] | Yuyin Ling : | Not mentioned blindness and drop-out rate |
|
| ||||||
| 102 | RCT | 76 | Treatment arms: Huoxue Quyu formula + ciprofloxacin | Treatment arm: PR, 39.5% [15 of 38] | Huoxue Quyu formula: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 103 | RCT | 80 | Treatment arm: Wenjing Tongluo decoction + Tubal hydrotubation | Treatment arm: PR, 67.5% [27 of 40] | Wenjing Tongluo Decoction: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 106 | RCT | 56 | Treatment arm: Bushen Culuan Decoction | There was no significant difference in outcomes of PR between two groups | Bushen Culuan Decoction: | Not mentioned blindness |
|
| ||||||
| 107 | RCT | 80 | Treatment arm: self-designed Bushen huoxue decoction + ethinylestradiol cyproterone tablets + clomiphene citrate capsules | Treatment arm: PR, 85% [34 of 40] | Self-designed Bushen huoxue Decoction: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 108 | RCT | 80 | Treatment arm: Shugan Jianpi formula + bromocriptine | Treatment arm: PR, 42.5% [17 of 40] | Shugan Jianpi formula: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 109 | Multicenter double-blind | 202 | Treatment arm: | Treatment arm: PR, 44.6% [45 of 101] | Huoxue Xiaoyi granule: | |
|
| ||||||
| 110 | RCT | 62 | Treatment arm: Bushen Yangjing granule + letrozole | Treatment arm: PR, 67.7% [21 of 31] | Bushen Yangjing granule: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 112 | RCT | 60 | Treatment arm: Bushen huoxue formula | Treatment arm: PR, 47.7% [14 of 30] | Bushen huoxue formula: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 113 | RCT | 120 | Treatment arm: Bushen Quyu decoction + laparoscopic surgery, and then gestrinone treatment | Treatment arm: PR, 68.3% [41 of 60] | Bushen Quyu decoction: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 114 | RCT | 70 | Treatment arm: Jinlinzi powder + sini powder + conventional western medicine | Treatment arm: PR, 82.86% [29 of 35] | Jinlinzi powder + Sini powder: | Not mentioned blindness and drop-out rate |
|
| ||||||
| 115 | RCT | 60 | Treatment arm: Jianpi Bushen Zhuluan formula + letrozole | Treatment arm: PR, 56.7% [17 of 30] | Jianpi Bushen Zhuluan formula: Dodder (Tu Si Zi), Radix codonopsis (Dang Shen), Dried radix rehmanniae (Sheng Di Huang), Yam (Shan Yao), prepared rehmannia root (Shu Di Huang), Lotus fruit (Lian Zi Rou), Radix scutellariae (Huang Qin), Radix glehniae (Bei Sha Shen), Dendrobe (Shi Hu), polygonatum (huang jing), rose (Mei Gui Hua), Sargentodoxa cuneata (Hong Teng), Citrus (Chen Pi), Tangerine leaf (Ju Ye) | Not mentioned blindness and drop-out rate |
Note: RCT: randomized clinical trial; PR: pregnancy rate; LBR: live birth rate. P< 0.05 versus treatment arm.
Clinical studies on retention enema in infertility treatment.
| Study ID | Design | Sample size | Interventions | Outcomes | Limitation |
|---|---|---|---|---|---|
| 146 | RCT | 92 | Treatment arm: penqiangyan prescription and TCM retention enema | Treatment arm: TE 80.43% | Not mentioned drop-out rate |
|
| |||||
| 147 | RCT | 53 | Treatment arm: hysteroscopy and TCM retention enema | Treatment arm: PR 55.56% | Not mentioned drop-out rate |
|
| |||||
| 148 | RCT | 50 | Treatment arm: laparoscopic surgery and TCM retention enema | Treatment arm: PR72% | Not mentioned drop-out rate |
|
| |||||
| 149 | RCT | 86 | Treatment arm: hysteroscopy and TCM retention enema | Treatment arm: PR 62.7% | Not mentioned drop-out rate |
|
| |||||
| 150 | RCT | 98 | Treatment arm: tubal interventional recanalization and TCM retention enema | Treatment arm: PR53.1% | Not mentioned drop-out rate |
|
| |||||
| 153 | RCT | 60 | Treatment arm: TCM retention enema, acupuncture and estradiol tablets | Treatment arm: TE 83.3% | Not mentioned drop-out rate |
Note: RCT: randomized clinical trial; PR: pregnancy rate; TE : total effective rate; P< 0.05 versus treatment arm.